Infectious Disorders - Drug Targets
Formerly: Current Drug Targets - Infectious Disorders
Volume 22, 8 Issues, 2022
ISSN: 2212-3989 (Online)
ISSN: 1871-5265 (Print)
This journal supports open access
ISSN: 2212-3989 (Online)
ISSN: 1871-5265 (Print)
This journal supports open access
Contents
Infectious Disorders - Drug Targets , Volume 9 - Number 1
Therapy in Prion Diseases: From Molecular and Cellular Biology to Therapeutic Targets
, 9(1): 3 - 14Carmen Krammer, Ina Vorberg, Hermann M. Schatzl and Sabine Gilch
DOI: 10.2174/1871526510909010003
Amyloidophilic Compounds for Prion Diseases
, 9(1): 15 - 22Kenta Teruya, Keiichi Kawagoe, Tomohiro Kimura, Chun-jen Chen, Yuji Sakasegawa and Katsumi Doh-ura
DOI: 10.2174/1871526510909010015
Tetracyclines and Prion Infectivity
, 9(1): 23 - 30Gianluigi Forloni, Mario Salmona, Gabriella Marcon and Fabrizio Tagliavini
DOI: 10.2174/1871526510909010023
Procedure for Identification and Characterization of Drugs Efficient Against Mammalian Prion: From a Yeast-Based Antiprion Drug Screening Assay to In Vivo Mouse Models
, 9(1): 31 - 39Cecile Voisset, Sven J. Saupe, Herve Galons and Marc Blondel
DOI: 10.2174/1871526510909010031
Inhibition of Prion Amplification by Expression of Dominant Inhibitory Mutants - A Systematic Insertion Mutagenesis Study
, 9(1): 40 - 47Markus Geissen, Harriet Mella, Armin Saalmuller, Martin Eiden, Juliane Proft, Eberhard Pfaff, Hermann M. Schatzl and Martin H. Groschup
DOI: 10.2174/1871526510909010040
Preventing Prion Pathogenicity by Targeting the Cellular Prion Protein
, 9(1): 48 - 57Andrew J. Nicoll and John Collinge
DOI: 10.2174/1871526510909010048
Gene and Cell Therapy for Prion Diseases
, 9(1): 58 - 68A. Relano-Gines, A. Gabelle, S. Lehmann, O. Milhavet and C. Crozet
DOI: 10.2174/1871526510909010058
LRP/LR as an Alternative Promising Target in Therapy of Prion Diseases, Alzheimers Disease and Cancer
, 9(1): 69 - 80Karen Vana, Chantal Zuber, Heike Pflanz, Dominika Kolodziejczak, Georgeta Zemora, Ann-Katrin Bergmann and Stefan Weiss
DOI: 10.2174/1871526510909010069
Recent Advances in Prion Chemotherapeutics
, 9(1): 81 - 91Valerie L. Sim and Byron Caughey
DOI: 10.2174/1871526510909010081
Editor-in-Chief
Jean-Marc Sabatier
Laboratoire ERT 62 'Ingénierie des peptides à visée thérapeutique'
Université de la Méditerranée
Faculté de Médecine Nord
Boulevard Pierre Dramard
13916 - MARSEILLE, Cedex 20
(France)
Biography
Laboratoire ERT 62 'Ingénierie des peptides à visée thérapeutique'
Université de la Méditerranée
Faculté de Médecine Nord
Boulevard Pierre Dramard
13916 - MARSEILLE, Cedex 20
Biography
Biography of Jean-Marc Sabatier
Jean-Marc SABATIER is a Director of research at the French CNRS, with PhD and HDR degrees in Biochemistry and Microbiology. He headed several academic research teams (CNRS, INSERM and University), as well as a combined academic-industry research laboratory devoted to the engineering of therapeutic peptides (ERT62, Marseilles, France). He was also a Director of Research for several French private companies as well as a Canadian public company. He acts as a Consultant for top pharmaceutical and cosmetic companies. Dr. Sabatier works in the field of animal toxins. He so far contributed to several books in toxinology and virology, and more than 160 scientific articles, 180 communications, and 53 patents in both biology and chemistry.
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Post Publication Discussions and Corrections⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Board Recruitment Workflow⇨ Short Guide⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments
For Authors
For Librarians & Readers
Quick Links
Webmaster Contact: info@benthamscience.net